Cited by 613Coffee research and impactsAgricultural safety and regulationsDye analysis and toxicity

The DOI matches its Crossref record; 294 of the 309 references it cites were found in a registry or an index, and 1 are not checked yet; none of the 175 sources its claims cite is checked for support yet.

Scientific Opinion on the safety of caffeine

Open access
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)·2015·EFSA Journal

Abstract

Following a request from the European Commission, the EFSA Panel on Dietetic Products, Nutrition and Allergies was asked to deliver a scientific opinion on the safety of caffeine, providing advice on caffeine intakes, from all dietary sources that do not give rise to concerns about adverse health effects for the general healthy population and subgroups thereof. Possible interactions between caffeine and other constituents of so-called “energy drinks”, alcohol, p-synephrine and physical exercise should also be addressed. Single doses of caffeine up to 200 mg (about 3 mg/kg bw for a 70-kg adult) do not give rise to safety concerns. The same amount does not give rise to safety concerns when consumed < 2 hours prior to intense physical exercise under normal environmental conditions. Other constituents of “energy drinks” at typical concentrations in such beverages (about 300–320, 4 000 and 2 400 mg/L of caffeine, taurine and d-glucurono-γ-lactone, respectively), as well as alcohol at doses up to about 0.65 g/kg bw, would not affect the safety of single doses of caffeine up to 200 mg. Habitual caffeine consumption up to 400 mg per day does not give rise to safety concerns for non-pregnant adults. Habitual caffeine consumption up to 200 mg per day by pregnant women does not give rise to safety concerns for the fetus. Single doses of caffeine and habitual caffeine intakes up to 200 mg consumed by lactating women do not give rise to safety concerns for breastfed infants. For children and adolescents, the information available is insufficient to derive a safe caffeine intake. The Panel considers that caffeine intakes of no concern derived for acute caffeine consumption by adults (3 mg/kg bw per day) may serve as a basis to derive single doses of caffeine and daily caffeine intakes of no concern for these population subgroups.

Checked 2026-10-10 · 1 reference not checked yet

Overview

AI snapshot

Written from a shortened version of the paper’s full text (it is longer than we read).

TL;DR

The EFSA NDA Panel concluded that single caffeine doses up to 200 mg (about 3 mg/kg bw for a 70-kg adult) and habitual intake up to 400 mg/day do not raise safety concerns for healthy non-pregnant adults, with lower levels for pregnant and lactating women. For children and adolescents, data were insufficient to derive a safe intake, but the Panel proposed 3 mg/kg bw/day for single and habitual consumption.

Key findings

  • For healthy adults, single doses of caffeine up to 200 mg (about 3 mg/kg bw for a 70-kg adult) from all sources do not give rise to safety concerns, including when consumed less than two hours before intense physical exercise under normal environmental conditions; 100 mg may increase sleep latency and reduce sleep duration in some adults, especially close to bedtime. Habitual caffeine intake up to 400 mg/day (about 5.7 mg/kg bw/day for a 70-kg adult) does not give rise to safety concerns for healthy adults, except pregnant women.
  • For pregnant women, habitual caffeine intake up to 200 mg/day does not give rise to safety concerns for the fetus; for lactating women, single doses up to 200 mg and habitual intake of 200 mg/day do not give rise to safety concerns for the breastfed infant, with infant intakes estimated not to exceed 0.3 mg/kg bw/day, 10-fold below the lowest tested dose of 3 mg/kg bw.
  • For children and adolescents, available information was insufficient to derive a safe caffeine intake; the Panel considered that the adult single-dose level of 3 mg/kg bw/day may also apply to children, and proposed 3 mg/kg bw/day for habitual consumption. The 95th percentile of single-day caffeine intake exceeded 3 mg/kg bw in 6/16 countries for adolescents, 9/16 for children, and 3/10 for toddlers, with proportions of survey days ranging from about 7–12%, 6–15%, and 7–37%, respectively.
  • Other common “energy drink” constituents at typical concentrations (about 300–320, 4,000, and 2,400 mg/L of caffeine, taurine, and D-glucurono-γ-lactone, respectively) and alcohol up to about 0.65 g/kg bw (blood alcohol concentration about 0.08%) would not affect the safety of single caffeine doses up to 200 mg; whether p-synephrine modifies acute cardiovascular effects of caffeine was not adequately investigated, so no conclusions could be drawn.

Methods

  • The EFSA NDA Panel conducted a scientific opinion based on previous risk assessments and human intervention and observational studies, preferring human intervention and prospective cohort studies over case-control and cross-sectional studies; case reports of adverse events were not used to derive levels of no concern.
  • Dietary caffeine intake was estimated using the EFSA Comprehensive European Food Consumption Database, containing 39 surveys in 22 European countries for 66,531 participants, plus the EFSA report on “energy drinks” involving more than 52,000 participants from 16 Member States for single-session intakes.
  • The assessment covered cardiovascular outcomes, hydration and body temperature, central nervous system outcomes (sleep, anxiety, perceived exertion, subjective alcohol intoxication), and pregnancy outcomes, using systematic reviews and meta-analyses where available.

Limitations

  • The paper states that data are particularly scarce for pregnant and lactating women, absent for caffeine-containing supplements, and that surveys differ in methodology so direct country-to-country comparisons should be cautious; no studies were available in pregnant women or middle-aged/elderly subjects undertaking intense physical exercise.
  • The paper states that p-synephrine interactions with caffeine have not been adequately investigated, that information for children and adolescents is insufficient to derive a safe intake, and that prospective cohort studies cannot prove causality for pregnancy outcomes, although the Panel assumed causality for the safety assessment.
  • Evident from the text: the “single session” time frame in the energy drink report is imprecise, energy drink consumers may not represent the general population, food-frequency questionnaires may overestimate consumption of specific foods, and observational studies are subject to confounding, reverse causality, and recall bias.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.2903/j.efsa.2015.4102

Cites

294 of 295 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

0 of 175 cited sources checked · 0 supported · 0 flagged

Show all 213 claims

  • It may state two separate claims as one. 162
  • The quote only partly states this claim. 15
  • Probably not a substantial claim. 46
194 of 194
  • The paper relies on this without support.

    Caffeine clearance in children and adolescents is at least that of adults.

    “considering that caffeine clearance in children and adolescents is at least that of adults”
    “As caffeine clearance in children and adolescents is at least that of adults”
    “considering that caffeine clearance in children and adolescents is at least that of adults”
    “As mentioned above, caffeine clearance in children and adolescents is at least that of adults.”
  • The paper relies on this without support.

    Caffeine is not an essential nutrient.

    “However, caffeine is not an essential nutrient, and thus ULs cannot be derived.”
  • The paper relies on this without support.

    No data show a higher sensitivity to the effects of caffeine in children and adolescents (i.e., difference in pharmacodynamics).

    “unless there are data showing a higher sensitivity to the effects of caffeine in this age group (i.e.difference in pharmacodynamics).”
  • The paper relies on this without support.

    Cocoa-based beverages might present significant variability in caffeine levels because of the amount and type of cocoa present in different brands.

    “Cocoa-based beverages are another food product that might present significant variability in caffeine levels because of the amount and type of cocoa present in the different brands.”
  • The paper relies on this without support.

    Food frequency questionnaires specifically developed to assess consumption of specific foods tend to overestimate consumption of such foods.

    “(ii) FFQs specifically developed to assess consumption of specific foods tend to overestimate consumption of such foods;”
  • The paper relies on this without support.

    The dietary surveys included in the EFSA Comprehensive Database provide representative estimates of caffeine intake for the respective populations.

    “Daily caffeine intake from all sources could be estimated for adults from 16 Member States.”
  • The paper relies on this without support.

    The EFSA energy drink report data are representative of energy drink consumers in the EU.

    “Data were available from 16 Member States (Zucconi et al., 2013).”
  • The paper relies on this without support.

    Caffeine is a non-selective competitive A2A receptor antagonist that counteracts the vasodilator effect of adenosine and other A2A receptor agonists in the coronary arteries, where the density of such receptors is particularly high.

    “Caffeine (like other methylxanthines) is a non-selective competitive A 2A receptor antagonist which counteracts the vasodilator effect of adenosine and other A 2A receptor agonists in the coronary arteries, where the density of such receptors is particularly high.”
  • The paper relies on this without support.

    The cardiac hyperaemic response to physical exercise is primarily mediated by endogenous production of adenosine by myocytes as a consequence of hypoxia, which induces vasodilation of the coronary arteries.

    “The cardiac hyperaemic response to physical exercise is primarily mediated by the endogenous production of adenosine by myocytes as a consequence of hypoxia, which induces vasodilation of the coronary arteries.”
  • The paper relies on this without support.

    p-Synephrine has direct stimulant effects on the sympathetic nervous system, primarily via the α1- and β-adrenoreceptors.

    “p-Synephrine has direct stimulant effects on the sympathetic nervous system, primarily via the α 1 -and β-adrenoreceptors.”
  • The paper relies on this without support.

    Synephrine is more hydrophilic than ephedrine and amphetamines, leading to lower transit across the blood-brain barrier and consequently lower or no central nervous system stimulation.

    “In contrast with ephedrine and amphetamines, which have known psychostimulating effects in the CNS, synephrine is more hydrophilic, which leads to a lower transit across the blood-brain barrier and consequently to lower, or no, CNS stimulation.”
  • The authors state this as an assumption.

    The perception of fatigue is a physiological mechanism leading to the spontaneous ending of physical activities that, because of their high intensity, extended duration or both, may compromise the cardiovascular and/or musculoskeletal systems.

    “under the assumption that the perception of fatigue is a physiological mechanism leading to the spontaneous ending of physical activities that, because of their high intensity, extended duration or both, may compromise the cardiovascular and/or musculoskeletal systems.”
  • The paper relies on this without support.

    FGR and SGA are associated with increased risk of perinatal morbidity and mortality.

    “FGR and SGA are associated with increased risk of perinatal morbidity and mortality.”
  • The paper relies on this without support.

    FGR is correlated with increased risk of metabolic diseases later in life.

    “FGR has been found to be correlated with increased risk of metabolic diseases later in life.”
  • The paper relies on this without support.

    Hypertension is an established risk factor for CVD, and in particular for stroke, CHD and heart failure.

    “Hypertension is an established risk factor for CVD, and in particular for stroke, CHD and heart failure.”
  • The authors state this as an assumption.

    The relationship between caffeine intake during pregnancy and adverse birth weight-related outcomes is causal in the context of this safety assessment.

    “the Panel assumes that the relationship is causal in the context of this safety assessment.”
  • The paper relies on this without support.

    The half-life of caffeine in women is mean four hours, range two to eight hours, and the half-life in infants is longer, namely 50-103 hours in neonates with no CYP1A2 activity and about 14 hours at three to four months of age.

    “the half-life of caffeine (mean four hours, range two to eight hours) in women and the longer half-life in infants (i.e.50-103 hours in neonates with no CYP1A2 activity, about 14 hours at three to four months of age).”
17 of 17

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

  • CARE study's energy-drink contribution is reported as both 1% and about 2%

    Minor

    The CARE study's source breakdown assigns energy drinks 1% of caffeine intake, while the later summary describes their contribution alone as about 2%.

1 of 1

Citations

Cites

Flagged first, then by citations

Show all 309 references

14 of the 309 references couldn’t be matched to a known paper.

Research works printed but not linked: 6

  1. EFSA (European Food Safety Authority), 2009, Scientific Opinion of the Panel on Food Additives and Nutrient Sources added to Food (ANS) on a request from the European Commission on the use of taurine and D‐glucurono‐γ‐lactone as constituents of the so‐called “energy” drinks, The EFSA Journal, 935, 1
  2. Evira, 2013, Food supplements containing synephrine and caffeine withdrawn from sale, 15, 22
  3. Jacobsen, 1986, Coffee drinking, mortality, and cancer incidence: results from a Norwegian prospective study, Journal of the National Cancer Institute, 76, 823
  4. Kalman, 2002, A double blind clinical evaluation of the metabolic effects of Xenadrine EFXTM compared to two ephedra‐containing products in normal healthy volunteers. Presented at the annual meeting of the American College of Nutrition, Abstract No. 101, Journal of the American College of Nutrition, 21, 488
  5. SHC (Superior Health Council), 2012, “The use of caffeine in foodstuffs”, 27
  6. Zhang, 2009, Coffee consumption and risk of cardiovascular disease and total mortality among women with type 2 diabetes, Circulation, 119, E298

Cited by

Sorted by citations

Items 601–612 of 612

Metadata

Authors
EFSA Panel on Dietetic Products, N. A. A. (.
Corresponding author
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
Venue
EFSA Journal
Publisher
Wiley
Published
2015-05
Volume
13
Issue
5
ISSN
1831-4732 (ISSN-L)
OpenAlex
W2556574846
Cited by
613
References
309
Citations by year
2026: 65 · 2025: 73 · 2024: 72 · 2023: 56 · 2022: 62 · 2021: 90 · 2020: 45 · 2019: 38 · 2018: 48 · 2017: 38 · 2016: 19 · 2015: 6
FWCI
26.70
Type
journal article
Language
en
Open access
Locations
  • EFSA Journal (publishedVersion, cc-by-nd)
  • Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Technical University of Denmark, DTU Orbit (Technical University of Denmark, DTU) (submittedVersion, other-oa)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Coffee research and impacts
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Agricultural safety and regulations
  • Physical Sciences › Chemistry › Analytical Chemistry › Dye analysis and toxicity
Keywords
caffeine, food safety, dietary intake, energy drinks, p-synephrine, alcohol, physical activity, taurine, pregnancy, lactation, breastfeeding, children and adolescents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review